The Effect of PAP on ISSHL Comorbided With OSA
The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study
Beijing Tsinghua Chang Gung Hospital
102 participants
Nov 1, 2019
INTERVENTIONAL
Conditions
Summary
This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.
Eligibility
Inclusion Criteria4
- aged \>= 18 and \<= 70,
- diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI \> 15/h,
- diagnosed with ISSHL by AAO-HNS 2019 criteria,
- ISSHL onset within 1 week.
Exclusion Criteria6
- sudden hearing loss with certain causes,
- with severe comorbid diseases,
- pregnant or breast-feeding women,
- AHI \<= 15/h,
- hearing threshold recovered \> 50% when included,
- previously regularly treated with PAP.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
non-invasive positive airway pressure is the first-line treatment for obstructive sleep apnea
Methylprednisolone is the first-line treatment of idiopathic sudden sensorineural hearing loss
ginnaton is ginkgo biloba extract
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04192656